Literature DB >> 17604519

Uterine sarcomas in Port Harcourt, Nigeria: a 12-year clinico-pathologic study.

D Seleye-Fubara1, S A Uzoigwe.   

Abstract

BACKGROUND: Uterine sarcomas are rare gynecological malignancies with a high mortality. There is the need to determine its frequency, clinical presentation and histologic variants. This may form the basis for further research and management in order to reduce the morbidity and mortality associated with it.
DESIGN: A 12-year hospital based retrospective clinico-pathological study.
SETTING: University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria. SUBJECT: Women with histologically diagnosed uterine sarcomas.
METHOD: Previously prepared histologic slides were retrieved and reviewed to confirm the diagnosis and to ascertain the histological type of the uterine sarcoma. Clinical data such as the age and the mode of presentation were extracted from the case notes, histology request forms and reports.
RESULTS: Eleven histological reports satisfied the criteria for the study which accounted for 0.5% and 4% of total malignancies and gynaecologic malignancies respectively in UPTH during the period under review. Malignant mixed mesodermal tumors was the most common (36.4%). The highest frequency of the tumors occurred in the age group 50-59 years (45.5%) and abnormal vaginal bleeding was the most common clinical presentation (36.4%).
CONCLUSION: Uterine Sarcomas are rare world wide; most common above the age of 50 years, with variable clinical presentations and associated with high morbidity and mortality rate.

Entities:  

Mesh:

Year:  2007        PMID: 17604519      PMCID: PMC2366131          DOI: 10.5555/afhs.2007.7.1.10

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  20 in total

Review 1.  Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.

Authors:  R Vang; L J Medeiros; C S Ha; M Deavers
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

2.  SARCOMA ARISING IN A LEIOMYOMA OF THE UTERUS: FACTORS INFLUENCING PROGNOSIS.

Authors:  A C MONTAGUE; D P SWARTZ; J D WOODRUFF
Journal:  Am J Obstet Gynecol       Date:  1965-06-01       Impact factor: 8.661

3.  Uterine sarcomas: histogenesis and taxonomy.

Authors:  W B OBER
Journal:  Ann N Y Acad Sci       Date:  1959-01-09       Impact factor: 5.691

4.  Patterns of metastasis in uterine sarcoma. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T Lau
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

5.  Soft tissue sarcomas in the Niger Delta Region of Nigeria (a referral hospital's study).

Authors:  D Seleye-Fubara; S O Nwosu; B E Yellowe; E Bob-Yellowe
Journal:  Niger J Med       Date:  2005 Apr-Jun

6.  Carcinosarcoma of the uterus with extensive neuroectodermal differentiation.

Authors:  M Fukunaga; K Nomura; Y Endo; S Ushigome; S Aizawa
Journal:  Histopathology       Date:  1996-12       Impact factor: 5.087

7.  Uterine sarcomas at Ramathibodi Hospital (1969-1986).

Authors:  S Tangtrakul; S Srisupundit; V Linasmita; S Bullangpoti; Y Bhamarapravati
Journal:  J Med Assoc Thai       Date:  1990-02

8.  [Uterine sarcoma. Apropos of 25 cases].

Authors:  O Bennani; A Himmi; M Laghzaoui; M Aderdour
Journal:  Rev Fr Gynecol Obstet       Date:  1995-01

9.  [Malignancy of uterine sarcoma in comparison with suspect leiomyoma. An anatomo-clinical study of 16 cases].

Authors:  R V Socolov; F Z Pricop; D Stratan
Journal:  Rev Fr Gynecol Obstet       Date:  1992-10

10.  [Sarcoma of the uterus].

Authors:  T Fait; P Freitag; J Zivný
Journal:  Ceska Gynekol       Date:  1998-08
View more
  2 in total

1.  African Health Sciences. Editorial.

Authors:  Michael G Kawooya
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

2.  Cervical leiomyosarcoma in a teenage girl: A rare form of uterine leiomyosarcoma.

Authors:  Adebayo A Adewole; Temitope G Onile; Austin O Ugiagbe; Oluwaseyi O Fadahunsi; Daniel I Awelimobor; Omotayo Akinro
Journal:  J Taibah Univ Med Sci       Date:  2021-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.